INTRODUCTION
Vitamin A is an important regulator ofgrowth and differentiation in most cells of the body. To fulfil this regulatory role, the physiological concentration of retinol in plasma is regulated within a narrow range. Thus in an individual with adequate vitamin A status most cells are exposed to about 2,M retinol bound to a specific plasma protein, the retinol-binding protein (RBP) [1, 2] . RBP is synthesized mainly in the liver parenchymal cells, but also in other cells and tissues such as liver stellate cells [3] , Sertoli cells [4] , kidney [5] , placenta (visceral yolk sac of rat) [6] and adipose tissue [5] . It has a molecular mass of 21 kDa and contains one binding site for its ligand, retinol [7] . The protein has several antiparallel fl-sheets forming a hydrophobic cleft for ligand binding [8] . In plasma, RBP forms a 76 kDa complex with transthyretin (TTR) which is large enough not to be lost in the glomeruli [7] .
After cellular uptake, most of the retinol is recycled to plasma, and only a small proportion is converted into retinoic acid, the active metabolite [9] . Several aspects of this processing, such as the mechanism for cellular uptake, have not yet been elucidated in detail. Although some early data suggested the existence of a specific RBP receptor, this has been questioned by several researchers [7, [10] [11] [12] [13] [14] . However, it now seems appropriate to conclude from recent evidence that a specific RBP receptor is involved in the cellular uptake of retinol. The strongest evidence supporting this includes selective uptake of iodinated RBP by a subgroup of cells in vivo [15] [16] [17] [18] [19] , and specific binding to cells [20] [21] [22] [23] [24] [25] and membrane preparations [26] [27] [28] in vitro. Furthermore, specific binding of RBP was demonstrated to the putative receptor solubilized from liver membranes [29] . Recently, a putative RBP receptor of molecular mass 63 kDa was cloned from retina pigment epithelial cells. This protein does not, however, enhance RBP uptake in transfected cells [30, 31] .
Experiments with both isolated cells [23] and membrane preparations [26, 28] have shown that the RBP-receptor complex dissociates with a half-life of less than 10 min. Thus I To whom correspondence should be addressed. 419 U.S.A.) supplemented with 10 % (v/v) fetal calf serum (Flow Laboratories), penicillin (100 units/ml), streptomycin (0.1 mg/ml), fungizone (2.5 ,ug/ml), gentamicin (0.2 mg/ml) and L-glutamine (2 mM). Sertoli cells were isolated from 18-week-old rats (immature) and cultivated for 5 days [32] before the experiments were carried out. Human keratinocytes were a gift from Dr. Rune Toftgard, Karolinska Institute, Huddinge, Sweden. They were cultured in serum-free MCDB 153 (Sigma) supplemented with CaCl2 (70 1tM), ethanolamine (0.1 mM), penicillin/streptomycin (10000 units/ml), fungizone (2.5 ,ug/ml), epidermal growth factor (10 ng/ml), hydrocortisone (0.4 ,ug/ml), insulin (5,tg/ml) and bovine pituitary extract (100 /ug/ml) and induced to differentiate with high Ca2+ (1.2 mM) [33] , adenine (0.18 nM) and 5 % fetal calf serum.
Isolation and labelling of RBP Human RBP was purified by a modification of the procedure of Vahlquist et al. [34] . An additional gel-filtration step (Sephadex G-75) was included in the final RBP preparation to obtain pure protein, as determined by SDS/PAGE and Coomassie Blue staining [35] . RBP was iodinated using the Enzymobead method as described in the instructions from the manufacturer. The iodinated RBP was used within 4 weeks of labelling.
Preparation of membrane vesicles Placenta membrane vesicles were prepared from freshly obtained human placenta as described by Booth et al. [36] . The purity of the final preparation was assessed by measuring the 5'-nucleotidase which increased more than 20-fold over that of the initial homogenates. The membranes were stored at -20°C at a concentration of 5-10 mg of protein/ml.
Pig brains were obtained in ice-cold 0.15 M NaCl 10-20 min after slaughter. The cortex, pineal gland and choroid plexus were dissected from the brain and placed in ice-cold buffer (20 mM Tris/HCl, pH 7.5, 150 mM NaCl and 4 mM MgCl2). The pineal gland was localized in the midline posterior, medial to the superior colliculus. All steps were carried out at 4 'C. The tissues were homogenized (5 ml of buffer/g of tissue) by ten strokes in a Potter-Elvehjem homogenizer and centrifuged at 800 g for 5 min to remove debris and unbroken cells. The supernatant was filtered through cheesecloth and centrifuged again at 800 g for 5 min. To isolate membrane vesicles the resulting supernatant was centrifuged at 100000 g for 60 min. The pellet was redissolved in 0.15 M NaCl to a concentration of 5-10 mg of protein/ml. This membrane vesicle preparation was stored at -20 'C, for up to 2 weeks without loss of activity.
Membrane vesicles from other tissues were prepared using the same procedure. Intestinal cells were scraped off the duodenum of a rabbit and washed in 0.15 M NaCl. Rabbit retina pigmented epithelium cells were isolated as described for rats [37] . Isolated cells were homogenized using a sonicator before centrifugation. The activity of the plasma-membrane marker 5'-nucleotidase in the final preparation was increased 2-5-fold over that of the initial homogenates.
Preparation of membrane vesicles from cells Cultured keratinocytes or fibroblasts were scraped off with a rubber 'policeman' and pelleted by centrifugation at 200 g for 10 min. The cell pellet was resuspended in an ice-cold hypotonic 20 mM Tris/HCl buffer, pH 7.5, containing 4 mM MgCl2 and homogenized by ten strokes in a Dounce homogenizer. The suspension was homogenized further by aspiration through a 25-gauge needle and gentle stirring on ice for 1 h. The subsequent centrifugation steps for isolation of membrane vesicles were identical with those described for isolation of membrane vesicles from organs.
Assay of membrane vesicle receptor binding 125I-RBP binding to membrane vesicle was assayed by using an oil-centrifugation method adapted from that described by Sivaprasadarao and Findlay [26] . Portions of membrane vesicles (50 p,l) were incubated with 50 1l of 1251I-RBP (about 50000 c.p.m. and 2 nM RBP) in a 20 mM sodium phosphate buffer, pH 7.4, containing 0.1 % ovalbumin and 150 mM NaCl. After incubation at room temperature for 15 min the membranes were centrifuged for 2 min at 12500 g, and 200 ,ul of a precooled phthalate oil mixture (3 parts of dibutyl phthalate and 2 parts of dinonyl phthalate) was added. Membrane-bound 1251-RBP was separated from unbound 1251-RBP by centrifugation for 1 min at 12 500 g. Three parallel incubations in the presence or absence of 2 ,tM unlabelled RBP were carried out to determine specific and non-specific binding. The tubes were then frozen in solid CO2, and the bottoms of the tubes containing the pellets were cut off and counted in a Packard y counter. Scatchard and correlation analyses were carried out using the software program Uptake of '251-RBP in tissues and organs Male Wistar rats were anaesthetized and 1251-RBP (1.5 x 106 c.p.m.) was injected in the femoral vein. At 30 min after injection a whole-body perfusion was performed (transcardic perfusion with PBS) to remove plasma containing radioactivity from the various organs. The different organs and tissues were then removed for analysis.
RESULTS

Binding activity in various tissues
In initial experiments, binding of 1251-RBP to human placenta membrane vesicles was studied. [26, 28, 38] . The tissue distribution of the putative RBP receptor was then studied by using this binding assay. Membrane vesicles from rabbit tissues were incubated with 2-10 nM 125I-labelled retinol-RBP in the absence (total binding) and presence (non-specific binding) of excess unlabelled RBP (2 mM) to determine specific binding activity. As shown in Table 1 , high specific binding activity was found in placenta, retina pigment epithelial cells, bone marrow and kidneys. Specific binding varied between 23 and 500% of total binding in these tissues. Specific binding activity was also found in the small intestine, spleen and liver, and to a lesser extent in lung and testis from mature rabbit. Specific binding in spleen and liver were 17 and 15 % of the total binding respectively; about 5 % of the total binding was specific in lung and testis and 2 % in the cortex of the cerebrum.
We then performed a Scatchard analysis of 125I-RBP binding to various membrane preparations; the results are summarized in Table 2 . Kd values were at the same level in placenta, kidney, bone marrow and liver. However, the Bmax values varied between the different organs from 1122 fmol/mg of membrane protein for placenta to 295 fmol/mg of membrane protein for liver. The data suggest that the differences in binding activity shown in Table 1 are a result of the difference in levels of expression of the RBP receptor in the tissues examined.
Tissue uptake of 1251-RBP In another series of experiments 125I-RBP was injected intravenously into rats. At 30 min after injection whole-body perfusion was performed and tissue samples were collected for determination ofligand uptake. The highest activity was observed in kidneys. Bone marrow, spleen, liver and small intestine also accumulated appreciable amounts of radioactivity (Table 3) . We chose to use Enzymobead-labelled RBP in these in vivo experiments instead of RBP linked to a non-degradable marker (such as tyramine cellobiose) as Malaba et al. [23] showed recently that this labelling method yields RBP that best retained its binding capacity to liver cells. After 30 min, more than 90 % of the radioactivity taken up in the liver and kidneys was acid precipitable and thus represented protein bound and not radioactivity from degraded RBP.
When these uptake data were plotted against the binding activity found in the cell-free binding assay, the overall correlation between binding in vitro and uptake in vivo was significant (R = 0.632; P < 0.05). These data suggest that the tissue uptake of 125I-RBP observed in vivo parallels the binding activities measured in the cell-free binding assay in vitro in most tissues. It should be added, however, that tissues from different species are compared in this experiment. Further experiment is therefore needed to substantiate this finding.
To ensure that the high uptake observed in kidneys was not due to reduced binding of 1251-RBP to TTR we tested the binding of 125I-RBP to a TTR affinity column. This affinity chromatography revealed that more than 95 % of the RBP bound to TTR.
Uptake and binding activity In kidney
In a previous study Smith et al. [39] reported that 1251-RBP injected intravenously into rats was mainly localized (by using autoradiography) in the cortex of the kidneys. In Binding activity in the brain MacDonald et al. [19] have shown that intravenously injected iodinated RBP was localized specifically to the cuboidal epithelial cells of the choroid plexus. The choroid plexus is a primary site of the blood-brain barrier and is therefore important in the delivery of nutrients to the cerebrospinal fluid. Thus we prepared membrane vesicles from the brain cortex, choroid plexus and also from the pineal gland (Table 4) . A very high specific binding activity was present in the choroid plexus. The pineal gland, which stores vitamin A in the brain, also showed high binding activity. In contrast, the brain cortex did not bind appreciable amounts of 125I-RBP.
Binding activity in testes
In testes the Sertoli cells form the tight blood-testis barrier. Retinol must cross this barrier and Sertoli cells are therefore expected to express the RBP receptor. We prepared testicular membrane vesicles from 15-and 22-week-old rabbits because these animals reached puberty at about 20 weeks of age. As shown in Table 4 , the binding activity in testis from immature animals was two to three times higher than testis from mature rabbits. As immature testis contains a higher proportion of Sertoli cells than germinal cells, these findings suggest that the RBP receptor is expressed predominantly in the former. The activity was therefore measured directly in Sertoli cell membrane vesicles from immature rats. The Sertoli cells were prepared from 18-day-old rats and cultivated for 5 days before analysis. As shown in Table 4 , these membrane preparations showed much higher binding activity than membrane vesicles isolated from whole testis.
Binding activity in skin
Retinoic acid is an important modulator of growth and differentiation of several cell types in the skin, including keratinocytes. The retinoic acid is probably formed in situ after delivery of retinol from the plasma retinol-RBP complex. We cultivated human keratinocytes in a defined medium and the same medium plus calcium, yielding basal undifferentiated cells and differentiated cells respectively [33] . As shown in Table 4 , membrane vesicles isolated from undifferentiated keratinocytes had about 40 times higher binding activity than differentiated cells. It should be noted that the binding activity in undifferentiated keratinocytes is the highest observed in all tissues and cells presented. In contrast, rabbit skin fibroblasts showed no binding activity.
DISCUSSION
By using the binding assay developed by Sivaprasadarao and Findlay [26] we have studied the tissue distribution of the RBP receptor by incubating 125I-RBP with membrane vesicles from various tissues. Separation of bound from unbound RBP by centrifugation through oil has an advantage over many other methods as it is rapid and does not involve prolonged centrifugations or washing steps which may dissociate the RBPreceptor complex. Because of the rapid dissociation of RBP from its receptor, we believe that the method using centrifugation through oil gives the best estimate of the tissue distribution of RBP receptor. Biavik et al. [28] used a cell-free binding-assay which separated bound from unbound ligand by two ultracentrifugation steps lasting 30 min each. They found highest binding activity in membrane vesicles prepared from retina pigment epithelium cells. Membrane vesicles prepared from liver and kidney expressed only 200 of the binding activity of retina pigment epithelium cells, and membrane vesicles from lung and muscle about 10% . These relative binding activities agree fairly well with our observations, although we detected higher relative binding activity in the kidneys.
In the present publications, we have also determined the binding activities in several other tissues and cells. First, we observed that placenta expressed even higher binding activity than the retina epithelium cells, and that the choroid plexus of the brain and Sertoli cells of the testis expressed relatively high binding activity. These are all cell types that have tight junctions and form a barrier between plasma and the interstitial fluid of the tissue. Thus plasma retinol must cross these cells in order to reach the target cells. These data are in agreement with an observation by MacDonald et al. [19] , who suggested that high levels of RBP receptors should be expressed in cells comprising blood-tissue barriers. This conclusion was based on autoradiographic localization of intravenously injected 1251I-RBP and the high level of immunoreactive cellular RBP found in cells forming blood-tissue barriers such as Sertoli cells, retina pigment epithelium cells and the cuboid cells of the choroid plexus.
Shingleton et al. [22] reported that uptake of [3H]retinol from the retinol-RBP complex by cultured Sertoli cells was specific and saturable. In our study, testis from immature animals with relatively more Sertoli cells showed higher binding activity than testis from mature rabbits. We also observed that membrane vesicles from isolated Sertoli cells expressed appreciable binding activity.
Several reports have emphasized the importance of retinoids in differentiation of haematopoietic and bone marrow cells [40, 41] . For example, it was shown that retinol complexed to RBP efficiently regulated growth and differentiation of myeloid cells [42] and the activation of B-cells [43] . Interestingly, in the present report we detected both high RBP-binding activity and in vivo uptake in bone marrow cells.
In kidney, almost all the specific RBP binding activity was recovered in the cortex where the proximal convoluted tubule has brush-border membranes. The high binding to the kidney cortex suggests that RBP primarily filtered in the glomeruli is taken up by the epithelial cells of the proximal convoluted tubuli. In addition, selective uptake of RBP was observed when we injected 1251-RBP intravenously into rats and determined recovery in tissues. These data are in agreement with an earlier observation by Katoh et al. [44] who found that filtered RBP was reabsorbed by the proximal tubular cells and degraded in lysosomes. In addition, an immunohistochemical study by Kato et al. [45] located RBP in the proximal convoluted tubular cells of the kidney.
The pineal gland is an organ that is rich in vitamin A and some retinoid-specific binding proteins [46] . The function of the organ and the role of vitamin A storage, however, remains unknown. Interestingly, in our in vitro binding assay we observed that membrane vesicles prepared from the pineal gland express about 7-8 times as much RBP-binding activity as the cerebral cortex.
We also detected high RBP-binding activity in non-differentiated human keratinocytes whereas differentiated keratinocytes showed almost no specific binding. Creek et al. [12] studied binding of 1251-RBP to keratinocytes using culture conditions yielding non-differentiated cells. They did not, however, observe any specific RBP binding. This contradictory result may be due to the extensive washing steps used in the study by Creek et al. [12] in contrast with the more rapid centrifugation-through-oil method used in the present study.
The non-differentiated keratinocytes represent basal cells located next to the capillaries. Our observation that nondifferentiated keratinocytes express RBP receptors whereas differentiated keratinocytes do not is interesting, as Torma et al. [47] suggested that keratinization in the skin is due to a functional vitamin A deficiency, i.e. when the cells migrate towards the upper layer of the epidermis they are exposed to lower levels of retinol-RBP, and therefore will differentiate. The observation that differentiated keratinocytes down-regulate the RBP receptor would correlate with such a regulation of differentiation.
The Kd of RBP-receptor binding found in the present study and in previous studies [23, 26, 28, 38] [28] find no effect of RBP binding whereas others [26] report that TTR inhibits the binding of RBP suggesting that uncomplexed RBP is the physiological ligand.
The results presented in the present report show that the RBP receptor concentration varies considerably from cell type to cell type and organ to organ. Furthermore, the tissue distribution of the receptor observed here correlates with uptake and appears to be physiotogical and consistent with previous knowledge of retinol function and metabolism by various cells. It is therefore reasonable to conclude that the level of RBP-receptor expression is an important regulator of tissue binding of RBP and thus probably also of uptake of retinol bound to RBP.
